Epigenetics: Relevance and implications for public health

Annual Review of Public Health

Volumn 35, Issue , 2014, Pages 105-122

  Rozek, Laura S ^a   Dolinoy, Dana C ^a   Sartor, Maureen A ^a,b   Omenn, Gilbert S ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Environmental epigenetics; Integrated bioinformatics; Life stage exposures; Molecular epidemiology; Risk assessment

Indexed keywords

BIOLOGICAL MARKER; DNA; FOOD ADDITIVE; HISTONE; CXXC1 PROTEIN, HUMAN; DNA BINDING PROTEIN;

ADULT DISEASE; ANIMAL MODEL; BIOINFORMATICS; BIOMICS; BIOSENSOR; CONFERENCE PAPER; CPG ISLAND; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; EPIGENETICS; HISTONE MODIFICATION; MOLECULAR EPIDEMIOLOGY; NUTRITIONAL STATUS; PERSONALIZED MEDICINE; PHENOTYPE; PRIORITY JOURNAL; PROTECTION; PUBLIC HEALTH; RISK ASSESSMENT; TOXICOLOGY; ADVERSE EFFECTS; ANIMAL; CARCINOGENESIS; EPIDEMIOLOGY; FEMALE; GENETIC EPIGENESIS; HEALTH BEHAVIOR; HUMAN; INFORMATION SYSTEM; METABOLISM; ORGANIZATION AND MANAGEMENT; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; RISK FACTOR; SOCIOECONOMICS;

ANIMALS; BIOMARKERS; CARCINOGENESIS; DNA-BINDING PROTEINS; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGIC RESEARCH DESIGN; EPIDEMIOLOGIC STUDIES; EPIGENESIS, GENETIC; FEMALE; HEALTH BEHAVIOR; HISTONES; HUMANS; INFORMATION SYSTEMS; NUTRITIONAL STATUS; PHENOTYPE; PRECISION MEDICINE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 84897097813     PISSN: 01637525     EISSN: 15452093     Source Type: Book Series    
DOI: 10.1146/annurev-publhealth-032013-182513     Document Type: Conference Paper

References (110)

1. Akalin A, Kormaksson M, Li S, Garrett-Bakelman FE, Figueroa ME, et al. 2012. MethylKit: A comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol. 13:R87
2. Anderson OS, Nahar MS, Faulk C, Jones TR, Liao C, et al. 2012. Epigenetic responses following maternal dietary exposure to physiologically relevant levels of bisphenol A. Environ. Mol. Mutagen. 53:334-42
3. Anderson OS, Peterson KE, Sanchez BN, Zhang Z,Mancuso P, Dolinoy DC. 2013. Perinatal bisphenol A exposure promotes hyperactivity, lean body composition, and hormonal responses across the murine life course. FASEB J. 27:1784-92
4. Arita A, Niu J, Qu Q, Zhao N, Ruan Y, et al. 2012. Global levels of histone modifications in peripheral blood mononuclear cells of subjects with exposure to nickel. Environ. Health Perspect. 120:198-203
5. Arora M, Kennedy BJ, Elhlou S, Pearson NJ, Walker DM, et al. 2006. Spatial distribution of lead in human primary teeth as a biomarker of pre- and neonatal lead exposure. Sci. Total Environ. 371:55-62
6. Baccarelli A, Wright RO, Bollati V, Tarantini L, Litonjua AA, et al. 2009. Rapid DNA methylation changes after exposure to traffic particles. Am. J. Respir. Crit. CareMed. 179:572-78
7. Behrman RE, Butler AS. 2006. Preterm Birth: Causes, Consequences, and Prevention. Washington, DC: Natl. Acad.
8. Bernal AJ, Dolinoy DC,Huang D, Skaar DA, Weinhouse C, Jirtle RL. 2013. Adaptive radiation-induced epigenetic alterations mitigated by antioxidants. FASEB J. 27:665-71
9. Bird A. 2002. DNA methylation patterns and epigenetic memory. Genes Dev. 16:6-21
10. Bollati V, Baccarelli A, Hou L, Bonzini M, Fustinoni S, et al. 2007. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 67:876-80
11. Bollati V, Baccarelli A, Sartori S, Tarantini L, Motta V, et al. 2010. Epigenetic effects of shiftwork on blood DNA methylation. Chronobiol. Int. 27:1093-104
12. Braun JM, Kalkbrenner AE, Calafat AM, Yolton K, Ye X, et al. 2011. Impact of early-life bisphenol A exposure on behavior and executive function in children. Pediatrics 128:873-82
13. Bygren LO. 2013. Intergenerational health responses to adverse and enriched environments. Annu. Rev. Public Health 34:49-60
14. Caiafa P, Zampieri M. 2005. DNA methylation and chromatin structure: the puzzling CpG islands. J. Cell Biochem. 94:257-65
15. Calafat A, Ye X, Wong L, Reidy J, Needham L. 2008. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ. Health Perspect. 116:39-44
16. Cantone L, Nordio F, Hou L, Apostoli P, Bonzini M, et al. 2011. Inhalable metal-rich air particles and histone H3K4 dimethylation and H3K9 acetylation in a cross-sectional study of steel workers. Environ. Health Perspect. 119:964-69
17. Champagne FA, Weaver IC, Diorio J, Dymov S, Szyf M, Meaney MJ. 2006. Maternal care associated with methylation of the estrogen receptor-α1b promoter and estrogen receptor-α expression in the medial preoptic area of female offspring. Endocrinology 147:2909-15
18. Chanda S, Dasgupta UB, Guhamazumder D, GuptaM, Chaudhuri U, et al. 2006. DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol. Sci. 89:431-37
19. Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, et al. 2012. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 148:1293-307
20. Cheung P, Lau P. 2005. Epigenetic regulation by histone methylation and histone variants. Mol. Endocrinol. 19:563-73
21. Chu F, Ren X, Chasse A, Hickman T, Zhang L, et al. 2011. Quantitative mass spectrometry reveals the epigenome as a target of arsenic. Chem. Biol. Interact. 192:113-17
22. Colaneri A, Staffa N, Fargo DC, Gao Y, Wang T, et al. 2011. Expanded methyl-sensitive cut counting reveals hypomethylation as an epigenetic state that highlights functional sequences of the genome. Proc. Natl. Acad. Sci. USA 108:9715-20
23. Dolinoy DC, Faulk C. 2012. The use of animal models to advance epigenetic science. ILAR J. 53:227-31
24. Dolinoy DC, Huang D, Jirtle RL. 2007. Maternal nutrient supplementation counteracts bisphenol A- induced DNA hypomethylation in early development. Proc. Natl. Acad. Sci. USA 104:13056-61
25. Dolinoy DC, Weidman JR, Waterland RA, Jirtle RL. 2006. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ. Health Perspect. 114:567-72
26. Doshi T, Mehta SS, Dighe V, Balasinor N, Vanage G. 2011. Hypermethylation of estrogen receptor promoter region in adult testis of rats exposed neonatally to bisphenol A. Toxicology 289:74-82
27. Dunham I, Birney E, Lajoie BR, Sanyal A, Dong X, et al. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489:57-74
28. Faustman EM, Omenn GS. 2013. Risk assessment. In Casarett and Doull's Toxicology: The Basic Science of Poisons, ed. CD Klaassen, pp. 123-49. New York: McGraw-Hill. 8th ed.
29. Feinberg AP. 2004. The epigenetics of cancer etiology. Semin. Cancer Biol. 14:427-32
30. Fish EW, Shahrokh D, Bagot R, Caldji C, Bredy T, et al. 2004. Epigenetic programming of stress responses through variations in maternal care. Ann. NY Acad. Sci. 1036:167-80
31. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, et al. 2005. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. USA 102:10604-9
32. Haberg SE, London SJ, Stigum H, Nafstad P, Nystad W. 2009. Folic acid supplements in pregnancy and early childhood respiratory health. Arch. Dis. Child. 94:180-84
33. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, et al. 2008. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl. Acad. Sci. USA 105:17046-49
34. Hertzman C. 2013. Commentary on the symposium: biological embedding, life course development, and the emergence of a new science. Annu. Rev. Public Health 34:1-5
35. Ho SM, Tang WY, Belmonte de Frausto J, Prins GS. 2006. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res. 66:5624-32
36. Hollingsworth JW, Maruoka S, Boon K, Garantziotis S, Li Z, et al. 2008. In utero supplementation with methyl donors enhances allergic airway disease in mice. J. Clin. Investig. 118:3462-69
37. Hsu PY, Deatherage DE, Rodriguez BA, Liyanarachchi S,Weng YI, et al. 2009. Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res. 69:5936-45
38. Hu H, Rabinowitz M, Smith D. 1998. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ. Health Perspect. 106:1-8
39. Huertas D, Soler M, Moreto J, Villanueva A, Martinez A, et al. 2011. Antitumor activity of a smallmolecule inhibitor of the histone kinase Haspin. Oncogene 31:1408-18
40. Javierre BM, Fernandez AF, Richter J, Al-Shahrour F, Martin-Subero JI, et al. 2010. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res. 20:170-79
41. Jenuwein T, Allis CD. 2001. Translating the histone code. Science 293:1074-80
42. Kantlehner M, Kirchner R, Hartmann P, Ellwart JW, Alunni-Fabbroni M, Schumacher A. 2011. A high-throughput DNA methylation analysis of a single cell. Nucleic Acids Res. 39:e44
43. Kile ML, Baccarelli A, Hoffman E, Tarantini L, Quamruzzaman Q, et al. 2012. Prenatal arsenic exposure and DNA methylation in maternal and umbilical cord blood leukocytes. Environ. Health Perspect. 120:1061-66
44. Kim J,Karnovsky A, Mahavisno V,WeymouthT, Pande M, et al. 2012. LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types. BMC Genomics 13:526
45. Kim JH, Rozek LS, Soliman AS, Sartor MA, Hablas A, et al. 2013. Bisphenol A-Associated epigenomic changes in prepubescent girls: A cross-sectional study in Gharbiah, Egypt. Environ. Health 12:33
46. Kouzarides T. 2007. Chromatin modifications and their function. Cell 128:693-705
47. Lai C-J, Bao R, Tao X,Wang J, Atoyan R, et al. 2010. CUDC-101, a multitargeted inhibitor of histone deacetylase, epidermal growth factor receptor, and human epidermal growth factor receptor 2, exerts potent anticancer activity. Cancer Res. 70:3647-56
48. Laird PW. 2010. Principles and challenges of genomewide DNA methylation analysis. Nat. Rev. Genet. 11:191-203
49. Lang IA, GallowayTS, Scarlett A, Henley WE,Depledge M, et al. 2008. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300:1303-10
50. Lave LB, Omenn GS. 1985. Cost-effectiveness of short-term tests for carcinogenicity. Nature 324:29-34
51. Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, et al. 2011. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471:68-73
52. Liu S, Im H, Bairoch A, Cristofanilli M, Chen R, et al. 2012. A chromosome-centric human proteome project (C-HPP) to characterize the sets of proteins encoded in chromosome 17. J. Proteome Res. 12:45-57
53. Maffini MV, Rubin BS, Sonnenschein C, Soto AM. 2006. Endocrine disruptors and reproductive health: the case of bisphenol-A. Mol. Cell Endocrinol. 254-255:179-86
54. Marko-Varga G, Omenn GS, Paik Y-K, HancockWS. 2012. A first step toward completion of a genomewide characterization of the human proteome. J. Proteome Res. 12:1-5
55. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, et al. 2010. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466:253-57
56. McGuinness D, McGlynn LM, Johnson PCD, MacIntyre A, Batty DG, et al. 2012. Socio-economic status is associated with epigenetic differences in the pSoBid cohort. Int. J. Epidemiol. 41:151-60
57. Meeker JD, Ehrlich S, Toth TL,Wright DL, Calafat AM, et al. 2010. Semen quality and sperm DNA damage in relation to urinary bisphenol A amongmen from an infertility clinic. Reprod. Toxicol. 30:532-39
58. Meeker JD, Hu H, Cantonwine DE, Lamadrid-Figueroa H, Calafat AM, et al. 2009. Urinary phthalate metabolites in relation to preterm birth in Mexico City. Environ. Health Perspect. 117:1587-92
59. Nahar MS, Liao C, Kannan K, Dolinoy DC. 2013. Fetal liver bisphenol A concentrations and biotransformation gene expression reveal variable exposure and altered capacity for metabolism in humans. J. Biochem. Mol. Toxicol. 27:116-23
60. Nahar MS, Soliman AS, Colacino JA, Calafat AM, Battige K, et al. 2012. Urinary bisphenol A concentrations in girls from rural and urban Egypt: A pilot study. Environ. Health 11:20
61. Natl. Res. Counc. 1983. Risk Assessment in the Federal Government: Managing the Process. Washington, DC: Natl. Acad.
62. Natl. Res. Counc. 1989. Biological Markers in Pulmonary Toxicology. Washington, DC: Natl. Acad.
63. Natl. Res. Counc. 2010. Toxicity Pathway-Based Risk Assessment: Preparing for Paradigm Change: A Symposium Summary. Washington, DC: Natl. Acad.
64. Nie Y, Liu H, Sun X. 2013. The patterns of histone modifications in the vicinity of transcription factor binding sites in human lymphoblastoid cell lines. PLoS ONE 8:e60002
65. Nilsson E, Larsen G,ManikkamM, Guerrero-Bosagna C, Savenkova MI, SkinnerMK. 2012. Environmentally induced epigenetic transgenerational inheritance of ovarian disease. PLoS ONE 7:e36129
66. O'Neill MS, Osornio-Vargas A, Buxton MA, Sanchez BN, Rojas-Bracho L, et al. 2012. Air pollution, inflammation and preterm birth inMexico City: study design andmethods. Sci. Total Environ. 448:79-83
67. O'Geen H, Echipare L, Farnham PJ. 2011. Using ChIP-seq technology to generate high-resolution profiles of histone modifications. In Methods in Molecular Biology, Vol. 791: Epigenetics Protocols, ed. TO Tollefsbol, pp. 265-86. New York: Humana
68. Odgers CL, Jaffee SR. 2013. Routine versus catastrophic influences on the developing child. Annu. Rev. Public Health 34:29-48
69. Omenn GS. 2012. Gene-environment interactions: eco-genetics and toxicogenomics. In Genomic and Personalized Medicine, ed. GS Ginsburg, HF Willard, pp. 50-59. London: Academic. 2nd ed.
70. Omenn GS, Stuebbe S, Lave LB. 1995. Predictions of rodent carcinogenicity testing results: interpretation in light of the Lave-Omenn value-of-information model. Mol. Carcinog. 14:37-45
71. Pavanello S, BollatiV, Pesatori AC, KapkaL, BolognesiC, et al. 2009. Global and gene-specific promoter methylation changes are related to anti-B[a]PDE-DNA adduct levels and influence micronuclei levels in polycyclic aromatic hydrocarbon-exposed individuals. Int. J. Cancer 125:1692-97
72. Perera F, Herbstman J. 2011. Prenatal environmental exposures, epigenetics, and disease. Reprod. Toxicol. 31:363-73
73. Perera F, Tang WY, Herbstman J, Tang D, Levin L, et al. 2009. Relation of DNA methylation of 5-CpG island of ACSL3 to transplacental exposure to airborne polycyclic aromatic hydrocarbons and childhood asthma. PLoS ONE 4:e4488
74. Perera FP, JedrychowskiW, RauhV,Whyatt RM. 1999. Molecular epidemiologic research on the effects of environmental pollutants on the fetus. Environ. Health Perspect. 107(Suppl. 3):451-60
75. Perera FP,Whyatt RM, Jedrychowski W, Rauh V, Manchester D, et al. 1998. Recent developments in molecular epidemiology: A study of the effects of environmental polycyclic aromatic hydrocarbons on birth outcomes in Poland. Am. J. Epidemiol. 147:309-14
76. Power C, Kuh D, Morton S. 2013. From developmental origins of adult disease to life course research on adult disease and aging: insights from birth cohort studies. Annu. Rev. Public Health 34:7-28
77. Pres./Congr. Comm. Risk Assess. Risk Manag. 1997. Risk Assessment and Risk Management in Regulatory Decision-Making. Washington, DC: US Gov. Print. Off.
78. Reichard JF, Puga A. 2010. Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics 2:87-104
79. Rudiger HW, Nowak D, Hartmann K, Cerutti P. 1985. Enhanced formation of benzo(a)pyrene:DNA adducts in monocytes of patients with a presumed predisposition to lung cancer. Cancer Res. 45:5890-94
80. Rusiecki JA, Baccarelli A, Bollati V, Tarantini L, Moore LE, Bonefeld-Jorgensen EC. 2008. Global DNA hypomethylation is associated with high serum-persistent organic pollutants in Greenlandic Inuit. Environ. Health Perspect. 116:1547-52
81. Saha A, Wittmeyer J, Cairns BR. 2006. Chromatin remodelling: the industrial revolution ofDNAaround histones. Nat. Rev. Mol. Cell Biol. 7:437-47
82. Sartor MA,Dolinoy DC, Rozek LS, Omenn GS. 2012. Bioinformatics for high-throughput toxicoepigenomic studies. In Toxicology and Epigenetics, ed. SC Sahu, pp. 569-88. New York: Wiley
83. Sartor MA, Leikauf GD, Medvedovic M. 2009. LRpath: A logistic regression approach for identifying enriched biological groups in gene expression data. Bioinformatics 25:211-17
84. Sartor MA, Mahavisno V, Keshamouni VG, Cavalcoli J, Wright Z, et al. 2010. ConceptGen: A gene set enrichment and gene set relation mapping tool. Bioinformatics 26:456-63
85. Schaub MA, Boyle AP, Kundaje A, Batzoglou S, Snyder M. 2012. Linking disease associations with regulatory information in the human genome. Genome Res. 22:1748-59
86. Skinner MK, Manikkam M, Guerrero-Bosagna C. 2011. Epigenetic transgenerational actions of endocrine disruptors. Reprod. Toxicol. 31:337-43
87. Sugiura-Ogasawara M, Ozaki Y, Sonta S, Makino T, Suzumori K. 2005. Exposure to bisphenol A is associated with recurrent miscarriage. Hum. Reprod. 20:2325-29
88. Susiarjo M, Sasson I, Mesaros C, Bartolomei MS. 2013. Bisphenol A exposure disrupts genomic imprinting in the mouse. PLoS Genet. 9:e1003401
89. Taher L, Ovcharenko I. 2009. Variable locus length in the human genome leads to ascertainment bias in functional inference for non-coding elements. Bioinformatics 25:578-84
90. Tang F, Barbacioru C, Wang Y, Nordman E, Lee C, et al. 2009. mRNA-Seq whole-transcriptome analysis of a single cell. Nat. Methods 6:377-82
91. Tang WY, Morey LM, Cheung YY, Birch L, Prins GS, Ho SM. 2012. Neonatal exposure to estradiol/bisphenol A alters promoter methylation and expression of Nsbp1 and Hpcal1 genes and transcriptional programs of Dnmt3a/b and Mbd2/4 in the rat prostate gland throughout life. Endocrinology 153:42- 55
92. Terry MB, Ferris JS, Pilsner R, Flom JD, Tehranifar P, et al. 2008. Genomic DNA methylation among women in a multiethnic New York City birth cohort. Cancer Epidemiol. Biomark. Prev. 17:2306-10
93. Tetz LM, Cheng A, Korte C, Giese R, Wang P, et al. 2013. Mono-2-ethylhexyl phthalate induces oxidative stress responses in human placental cells in vitro. Toxicol. Appl. Pharmacol. 268:47-54
94. Trasande L, Attina TM, Blustein J. 2012. Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA 308:1113-21
95. Tremolizzo L, Doueiri M-S, Dong E, Grayson DR, Davis J, et al. 2005. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol. Psychiatry 57:500-9
96. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. 2006. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 9:519-25
97. Tsankova NM, Kumar A, Nestler EJ. 2004. Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J. Neurosci. 24:5603-10
98. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder G. 2010. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ. Health Perspect. 118:1055-70
99. Vandenberg LN, ColbornT,Hayes TB,Heindel JJ, JacobsDRJr, et al. 2012. Hormones and endocrinedisrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr. Rev. 33:378-455
100. Virani S, Colacino JA, Kim JH, Rozek LS. 2012. Cancer epigenetics: A brief review. ILAR J. 53:359-69
101. Weng YI, Hsu PY, Liyanarachchi S, Liu J, Deatherage DE, et al. 2010. Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells. Toxicol. Appl. Pharmacol. 248:111-21
102. Wiencke J, Zheng S, Morrison Z, Yeh R. 2007. Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells. Oncogene 27:2412-21
103. Wright RO, Schwartz J,Wright RJ, Bollati V, Tarantini L, et al. 2010. Biomarkers of lead exposure and DNA methylation within retrotransposons. Environ. Health Perspect. 118:790-95
104. Wu G, Yi N, Absher D, Zhi D. 2011. Statistical quantification of methylation levels by next-generation sequencing. PLoS ONE 6:e21034
105. Yacqub-UsmanK,DuongCV, Clayton RN, Farrell WE. 2012. Epigenomic silencing of the BMP-4 gene in pituitary adenomas: A potential target for epidrug-induced re-expression. Endocrinology 153:3603-12
106. Yaoi T, Itoh K, Nakamura K, Ogi H, Fujiwara Y, Fushiki S. 2008. Genome-wide analysis of epigenomic alterations in fetal mouse forebrain after exposure to low doses of bisphenol A. Biochem. Biophys. Res. Commun. 376:563-67
107. Yavartanoo M, Choi JK. 2013. ENCODE: A sourcebook of epigenomes and chromatin language. Genomics Inform. 11:2-6
108. YoungMD, Wakefield MJ, Smyth GK, Oshlack A. 2010. Gene ontology analysis for RNA-seq: Accounting for selection bias. Genome Biol. 11:R14
109. Zang C, Schones DE, Zeng C, Cui K, Zhao K, PengW. 2009. A clustering approach for identification of enriched domains from histone modification ChIP-Seq data. Bioinformatics 25:1952-58
110. Zhang Z, Alomirah H, Cho HS, Li YF, Liao C, et al. 2011. Urinary bisphenol A concentrations and their implications for human exposure in several Asian countries. Environ. Sci. Technol. 45:7044-50